Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
ACUPHARMA ApS
APS
Active
Advertising protection
CVR 10072956
Kong Haralds Vej 4, 4000
Roskilde
Wholesale of other food
·
NACE 4638
Est. 2001 · 25 years old
2 employees
www.acupharma.dk
Monitor
Share
Denmark
/
Companies
/
Wholesale of other food
/
ACUPHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
1.151
610
1.128
778
1.185
Staff expenses
-811
-815
-724
-921
-908
EBITDA
340
-100
404
-206
277
Depreciation & amort.
-55
52
-105
-111
-174
EBIT
285
-153
300
-318
103
Net financials
-78
-106
-146
-102
-94
Profit before tax
207
-259
153
-420
8
Tax
-80
-0
-0
30
2
Net profit
288
-259
153
-450
6
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
2.152
1.820
2.103
2.011
2.397
Equity
-109
-397
-138
-291
158
Long-term debt
28
26
26
25
24
Short-term debt
2.233
2.191
2.216
2.277
2.215
Total debt
2.261
2.216
2.242
2.302
2.239
Financial ratios
5-year trend
EBITDA margin (of gross profit)
29,6 %
This company
2021
2025
Equity ratio
-5,1 %
This company
38,2 %
Market median
This company
Market median
113% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin (of gross profit)
25,0 %
This company
2021
2025
Asset turnover (of gross profit)
0,53×
This company
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
More on ACUPHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
